Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Affimed N.V. - Common Stock (NQ: AFMD )

0.8782 -0.0018 (-0.20%)
Streaming Delayed Price Updated: 2:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Affimed N.V. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Affimed Reports 2023 Financial Results and Operational Progress
From Affimed N.V.
Via GlobeNewswire
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
A Preview Of Affimed's Earnings
Via Benzinga
Recap: Affimed Q3 Earnings
Via Benzinga
Earnings Outlook For Affimed
Via Benzinga
Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024
From Affimed N.V.
Via GlobeNewswire
ASTR Stock Alert: Astra Space Is Going Private
Astra Space stock is in the news Friday as ASTR investors react to news that the company is being taken private in Q2 2024. 
Via InvestorPlace
Why Is AerSale (ASLE) Stock Down 18% Today?
AerSale stock is down on Friday as investors in ASLE react to misses in the aftermarket commercial aircraft seller's Q4 2024 earnings report. 
Via InvestorPlace
Why Is Affimed (AFMD) Stock Moving Today?
Affimed stock is on the move Friday as investors prepare for AFMD shares to undergo a one-for-10 reverse split later today. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! 
Via InvestorPlace
7 of the Best Speculative Stocks You Can Snag for Less Than $1
Although speculative stocks under $1 are by their very nature extremely risky, these ideas might have enough to go the distance. 
Via InvestorPlace
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning! 
Via InvestorPlace
Affimed Announces 1-for-10 Reverse Stock Split
From Affimed N.V.
Via GlobeNewswire
Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Leadership Change and Organizational Restructuring
From Affimed N.V.
Via GlobeNewswire
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers with all of the latest coverage worth reading about on Wednesday morning! 
Via InvestorPlace
Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck
From Affimed N.V.
Via GlobeNewswire
3 Penny Stocks That Are Too Compelling to Ignore
Although the sector presents extraordinary risks, for those seeking extreme returns, these top penny stocks to buy could get it done. 
Via InvestorPlace
Affimed Announces Positive Data for AFM24 in Combination with the PD-L1 Checkpoint Inhibitor Atezolizumab in Heavily Pre-treated EGFR-Wildtype Non-Small Cell Lung Cancer Patients
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)
From Affimed N.V.
Via GlobeNewswire
Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24
From Affimed N.V.
Via GlobeNewswire
Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Acimtamig as International Nonproprietary Name for AFM13
From Affimed N.V.
Via GlobeNewswire
Affimed to Report Third Quarter 2023 Financial Results & Corporate Update on November 14, 2023
From Affimed N.V.
Via GlobeNewswire
Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the trading week right with a breakdown of the biggest pre-market stock movers worth noting on Monday morning! 
Via InvestorPlace
Affimed Presents Preclinical Data Showing that Addition of an Innate Cell Engager to NK and CAR-NK Cells Improves Tumor Cytotoxicity of Both Cell Types at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting
From Affimed N.V.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.